Study | Years of inclusion | Study arms | Patients (n) | RT dose | Chemotherapy | Follow-up time (months) | Number of ENF |
---|---|---|---|---|---|---|---|
RCTs | |||||||
Yuan 2007 | 1997–2001 | IFRT | 100 | 68-74Gy | Concurrent | 27 (median) | 7 |
ENI | 100 | 60-64Gy | 27 (median) | 4 | |||
Yang 2007 | 2002–2004 | IFRT | 29 | 66-74Gy | Sequential | Till December 2005 | 3 |
ENI | 26 | 56-70Gy | Till December 2005 | 1 | |||
Chen 2013 | 2002–2011 | IFRT | 45 | 38-74Gy | Concurrent | 14.1 (median) | 2 |
ENI | 54 | 32-70Gy | 14.1 (median) | 4 | |||
Cohort studies | |||||||
Fernandes 2010 | 2003–2008 | IFRT | 48 | 60-84Gy | Concurrent or sequential | 13.5 (median) | 6 |
ENI | 60 | 54-72Gy | 17 (median) | 7 | |||
Kolodziejczyk 2012 | 2008–2009 | IFRT | 35 | 58.8Gy | Sequential | 32 (median) | 1 |
ENI | 17 | 58.8Gy | 32 (median) | 0 | |||
Topkan 2015 | 2007–2012 | IFRT | 143 | 60–66Gy | Concurrent | 23.3 (median) | 3 |
ENI | 844 | 60–66Gy | 23.3 (median) | 21 |